99 related articles for article (PubMed ID: 2683188)
1. Elevated plasminogen activator inhibitor (PAI), a cause of thrombophilia? A study in 203 patients with familial or sporadic venous thrombophilia.
Engesser L; Brommer EJ; Kluft C; Briët E
Thromb Haemost; 1989 Sep; 62(2):673-80. PubMed ID: 2683188
[TBL] [Abstract][Full Text] [Related]
2. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
[TBL] [Abstract][Full Text] [Related]
3. [Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia].
Tóth O; Dávid M; Habon T; Nagy A; Keszthelyi Z; Kovács N; Losonczy H
Orv Hetil; 2005 Oct; 146(41):2121-5. PubMed ID: 16304806
[TBL] [Abstract][Full Text] [Related]
4. A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency.
Zöller B; García de Frutos P; Dahlbäck B
Thromb Haemost; 1998 Apr; 79(4):802-7. PubMed ID: 9569196
[TBL] [Abstract][Full Text] [Related]
5. [Disorders of the liberation of tissue-type plasminogen activator (t-PA) from the venous wall as a cause for recurrent thromboses].
Hach-Wunderle V; Scharrer I
Vasa Suppl; 1993; 39():5-10. PubMed ID: 8322122
[TBL] [Abstract][Full Text] [Related]
6. Familial idiopathic osteonecrosis mediated by familial hypofibrinolysis with high levels of plasminogen activator inhibitor.
Glueck CJ; Glueck HI; Welch M; Freiberg R; Tracy T; Hamer T; Stroop D
Thromb Haemost; 1994 Feb; 71(2):195-8. PubMed ID: 8191398
[TBL] [Abstract][Full Text] [Related]
7. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
[TBL] [Abstract][Full Text] [Related]
8. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
9. Familial association of high levels of histidine-rich glycoprotein and plasminogen activator inhibitor-1 with venous thromboembolism.
Angles-Cano E; Gris JC; Loyau S; Schved JF
J Lab Clin Med; 1993 May; 121(5):646-53. PubMed ID: 8478593
[TBL] [Abstract][Full Text] [Related]
10. Prospective double-arm study of fibrinolysis in surgical patients.
Kosir MA; Schmittinger L; Barno-Winarski L; Duddella P; Pone M; Perales A; Lange P; Brish LK; McGee K; Beleski K; Pawlak J; Mammen E; Sajahan NP; Kozol RA
J Surg Res; 1998 Jan; 74(1):96-101. PubMed ID: 9536981
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
[TBL] [Abstract][Full Text] [Related]
12. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
[TBL] [Abstract][Full Text] [Related]
13. Relationship between serum angiotensin-converting enzyme activity and plasma plasminogen activator inhibitor activity in patients with recent myocardial infarction.
Moriyama Y; Ogawa H; Oshima S; Arai H; Takazoe K; Shimomura H; Hirai N; Suefuji H; Soejima H; Nishiyama K; Misumi K; Yasue H
Coron Artery Dis; 1998; 9(10):691-6. PubMed ID: 9894621
[TBL] [Abstract][Full Text] [Related]
14. Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity.
Agren A; Wiman B; Schulman S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):657-60. PubMed ID: 17890953
[TBL] [Abstract][Full Text] [Related]
15. Familial high plasminogen activator inhibitor with hypofibrinolysis, a new pathophysiologic cause of osteonecrosis?
Glueck CJ; Glueck HI; Mieczkowski L; Tracy T; Speirs J; Stroop D
Thromb Haemost; 1993 May; 69(5):460-5. PubMed ID: 8322268
[TBL] [Abstract][Full Text] [Related]
16. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis.
Juhan-Vague I; Valadier J; Alessi MC; Aillaud MF; Ansaldi J; Philip-Joet C; Holvoet P; Serradimigni A; Collen D
Thromb Haemost; 1987 Feb; 57(1):67-72. PubMed ID: 3109059
[TBL] [Abstract][Full Text] [Related]
17. Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene.
Erickson LA; Fici GJ; Lund JE; Boyle TP; Polites HG; Marotti KR
Nature; 1990 Jul; 346(6279):74-6. PubMed ID: 2366866
[TBL] [Abstract][Full Text] [Related]
18. Inherited fibrinolytic disorder due to an enhanced plasminogen activator level.
Aznar J; Estellés A; Vila V; Regañón E; España F; Villa P
Thromb Haemost; 1984 Oct; 52(2):196-200. PubMed ID: 6543037
[TBL] [Abstract][Full Text] [Related]
19. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR
Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044
[TBL] [Abstract][Full Text] [Related]
20. Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies.
Colucci M; Altomare DF; Chetta G; Triggiani R; Cavallo LG; Semeraro N
Thromb Haemost; 1988 Aug; 60(1):25-9. PubMed ID: 3142090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
